0000899243-22-022620.txt : 20220615 0000899243-22-022620.hdr.sgml : 20220615 20220615170533 ACCESSION NUMBER: 0000899243-22-022620 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220613 FILED AS OF DATE: 20220615 DATE AS OF CHANGE: 20220615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRANTE DOMENIC J CENTRAL INDEX KEY: 0001213397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40227 FILM NUMBER: 221018457 MAIL ADDRESS: STREET 1: BROOKSIDE CAPITAL MANAGEMENT LLC STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Finch Therapeutics Group, Inc. CENTRAL INDEX KEY: 0001733257 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823433558 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 INNER BELT ROAD CITY: SOMERVILLE STATE: MA ZIP: 02143 BUSINESS PHONE: 617-229-6499 MAIL ADDRESS: STREET 1: 200 INNER BELT ROAD CITY: SOMERVILLE STATE: MA ZIP: 02143 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-13 0 0001733257 Finch Therapeutics Group, Inc. FNCH 0001213397 FERRANTE DOMENIC J C/O FINCH THERAPEUTICS GROUP, INC. 200 INNER BELT ROAD, SUITE 400 SOMERVILLE MA 02143 1 0 0 0 Stock Option (right to buy) 2.79 2022-06-13 4 A 0 44843 0.00 A 2032-06-12 Common Stock 44843 44843 D The shares subject to this option shall vest in twelve equal monthly installments beginning on July 13, 2022, subject to the Reporting Person continuing to provide service through each such date. By: /s/ Joseph Vittiglio, Attorney-in-Fact 2022-06-15